The proposed "End Organ and Genomic Harvesting Act" aims to prohibit certain practices related to human organ transplants and genetic analysis technologies. Specifically, it prohibits health benefit plans from covering human organ transplants or post-transplant care if the transplant is performed in countries known for forced organ harvesting, such as the People's Republic of China. Additionally, the act restricts the use of genetic sequencers and operational software produced by foreign adversaries, mandating that medical and research facilities in Arkansas must not utilize such technologies for genetic analysis. Facilities are required to remove any prohibited equipment and may seek reimbursement for replacement costs from the state.

The act also establishes definitions for key terms, including "forced organ harvesting" and "health benefit plan," and outlines the responsibilities of the Insurance Commissioner in designating countries involved in forced organ harvesting. Furthermore, it mandates that genetic sequencing data must be stored within the United States and sets penalties for violations, including fines for entities that fail to comply with the regulations. The act emphasizes the importance of cybersecurity measures for genetic data and provides protections for whistleblowers who report violations.